Medinet•Piasu【Surge】Piarā•Bōdoruā Upward!! Shionogi Pharmaceutical【Great Drop】
Regarding the press coverage of the new coronavirus disease treatment S-217622 Shionogi Pharmaceutical Co., Ltd. (headquarters: Chuo-ku, Osaka; President and CEO: Isao Tatehaya; hereinafter "Shionogi Pharmaceutical") would like to inform you that it has summarized its views on the information reported since yesterday regarding the new coronavirus disease treatment S-217622 (hereinafter, "this treatment").
× ![]()